Mylan mondrianaccess state

At Mylan, delivering better health for a better New Jersey isn't our job.
It's our mission.

We believe everyone deserves the opportunity to live a healthy life, including you. That’s why, for more than 55 years, Mylan has been committed to providing access to high quality medicine and setting new standards in healthcare.

Better Health for a Better New Jersey

Scroll

ACCESS TO MEDICINE

In 2016, Mylan generics saved New Jersey

$700 million
We believe everyone deserves the opportunity to live a healthy life, including you. That's why our business is predicated on providing a sustainable supply of high quality medicine that is accessible, acceptable, available and affordable to patients around the world.
Mylan pig
Scroll

INNOVATION & SCIENCE

Mylan building state

Innovation and science are cornerstones of Mylan's success over the last 50+ years. They will continue to be the foundation of our future.

Mylan has global research centers in the U.S. and India and 10 technology-focused sites around the world.
Scroll

PUBLIC HEALTH & POLICY

Mylan GettyImages

One of the most powerful ways to serve patients in need is by speaking out on their behalf.

We work closely with government, trade associations, healthcare providers, patient advocacy groups and others to shape policy to help people in the U.S. enjoy better health.

Scroll

COMMUNITY IMPACT

Mylan charity state

Mylan understands the importance of going beyond our business boundaries to serve the community at large. Through community engagement and philanthropy, we drive access to high quality medicine and build healthy communities, often aligning our community support to our mission and core business through product donations, financial contributions and employee volunteerism.

Through one of our distribution partners, Dispensary of Hope, Mylan has donated ~3,180 doses of medicine to patients in New Jersey since 2012.

Scroll

Mylan's School Access Program - NJ

Epinephrine is the only first-line treatment for anaphylaxis, a potentially life-threatening allergic reaction. Several years ago, we recognized that epinephrine auto-injectors needed to be as accessible as defibrillators are in public spaces. So Mylan advocated for legislation to permit “undesignated” epinephrine auto-injectors in schools – meaning a prescription could be in a school’s name rather than in a child’s name and any individual experiencing an anaphylactic emergency would have access to the epinephrine auto-injectors. Today, 48 states have adopted such laws, and Mylan has donated nearly 1 million epinephrine auto-injectors to more than 73,000 schools around the country through the school access program.

Since the program began, epinephrine auto-injectors provided through the program have been used at least 159 times in New Jersey in the school setting.
Over the past five years, Mylan has provided 63,452 free epinephrine auto-injectors to 3,537 schools in NJ, ~81% of the state’s schools.